Wegovy, the only form of semaglutide approved for weight loss, is intended for use by those with either of the following: a BMI of 27 or greater and one weight-related health condition, such as high blood pressure a BMI of 30 or greater Both Ozempic and Rybelsus are intended for use in people with type 2 diabetes
Women with obesity often experience menstrual irregularities due to hormonal imbalances, insulin resistance, and conditions such as polycystic ovary syndrome (PCOS)
At Prefusion Health, every peptide stack is data-verified, medically supervised, and integrated with DEXA body composition scans, VO Max testing, RMR metabolic testing, Red Light Therapy, and IV support, ensuring your results are objective, not assumed
Yes, especially when dosed conservatively and monitored by a professional
Conclusion: Your Next Best Steps Ozempic can be an effective tool for managing Type 2 diabetes and supporting weight loss, but rapid changes in the body can temporarily impact the hair growth cycle